Side-by-side comparison

PFE vs MRK — Side-by-side comparison

PFE screens cheaper on EV/FCF, MRK has the higher ROIC, MRK has grown revenue faster over five years, and Neither has the cleaner balance sheet by net debt / EBITDA.

PFE

Pfizer Inc.

Price

$25.90

Market cap

$135.4B

Day %

N/A

MRK

Merck & Co.

Price

$122.41

Market cap

$208.5B

Day %

N/A

Peer Comparison

Target stock against 1 market-cap comparable peer.

Heat map: red worst to green best


PFE Target	Pfizer Inc.	$135.4B	19.0x	14.8x	9.0%	8.5%	14.5%	N/A	N/A	N/A
MRK	Merck & Co.	$208.5B	16.8x	15.7x	34.7%	9.4%	19.0%	N/A	N/A	N/A

PFE implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

14.8x

FCF yield

6.7%

5Y rev CAGR

8.5%

MRK implied-growth snapshot

Simple static valuation context using owner earnings yield and realized growth.

EV/FCF

15.7x

FCF yield

5.9%

5Y rev CAGR

9.4%

5Y indexed stock chart

Static Recharts view indexed to 100 from available annual per-share data.

Quality Scorecard

Build-time composite score for PFE.

Grade D

/ 100

Quality Scorecard

Build-time composite score for MRK.

Grade C

/ 100